• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class

tetano

Editor, Senior Moderator
Cell Rep


. 2021 Mar 19;108950.
doi: 10.1016/j.celrep.2021.108950. Online ahead of print.
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class


Micah Rapp[SUP] 1 [/SUP], Yicheng Guo[SUP] 2 [/SUP], Eswar R Reddem[SUP] 1 [/SUP], Jian Yu[SUP] 3 [/SUP], Lihong Liu[SUP] 3 [/SUP], Pengfei Wang[SUP] 3 [/SUP], Gabriele Cerutti[SUP] 1 [/SUP], Phinikoula Katsamba[SUP] 4 [/SUP], Jude S Bimela[SUP] 4 [/SUP], Fabiana A Bahna[SUP] 4 [/SUP], Seetha M Mannepalli[SUP] 4 [/SUP], Baoshan Zhang[SUP] 5 [/SUP], Peter D Kwong[SUP] 6 [/SUP], Yaoxing Huang[SUP] 3 [/SUP], David D Ho[SUP] 3 [/SUP], Lawrence Shapiro[SUP] 7 [/SUP], Zizhang Sheng[SUP] 8 [/SUP]



Affiliations

Abstract

Antibodies with heavy chains that derive from the VH1-2 gene constitute some of the most potent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibodies yet identified. To provide insight into whether these genetic similarities inform common modes of recognition, we determine the structures of the SARS-CoV-2 spike in complex with three VH1-2-derived antibodies: 2-15, 2-43, and H4. All three use VH1-2-encoded motifs to recognize the receptor-binding domain (RBD), with heavy-chain N53I-enhancing binding and light-chain tyrosines recognizing F486[SUB]RBD[/SUB]. Despite these similarities, class members bind both RBD-up and -down conformations of the spike, with a subset of antibodies using elongated CDRH3s to recognize glycan N343 on a neighboring RBD-a quaternary interaction accommodated by an increase in RBD separation of up to 12 ?. The VH1-2 antibody class, thus, uses modular recognition encoded by modular genetic elements to effect potent neutralization, with the VH-gene component specifying recognition of RBD and the CDRH3 component specifying quaternary interactions.

Keywords: COVID-19; RBD; SARS-CoV-2; multi-donor antibody class; neutralizing antibody; quaternary recognition; spike.
 
Back
Top Bottom